Liesl S. Eibschutz

Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease

Juliane Totzke, Deepak Gurbani, Rene Raphemot et al. · Cell chemical biology · 2017 · 126 citations · Full text

Selective Tak1 Inhibitor, Cancer Immunosurveillance, Autoimmune Disease +11

Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice

Scott A. Scarneo, Liesl S. Eibschutz, Phillip J. Bendele et al. · Arthritis Research & Therapy · 2019 · 49 citations · Full text

Genetic and pharmacological validation of TAK1 inhibition in macrophages as a therapeutic strategy to effectively inhibit TNF secretion

Scott A. Scarneo, Antoine Mansourati, Liesl S. Eibschutz et al. · Scientific Reports · 2018 · 32 citations · Full text

TAK1 regulates the tumor microenvironment through inflammatory, angiogenetic and apoptotic signaling cascades

Scott A. Scarneo, Kelly W. Yang, Jose Roques et al. · Oncotarget · 2020 · 12 citations · Full text

Artificial intelligence in the detection of non-biological materials

Liesl S. Eibschutz, Max Yang Lu, Mashya T. Abbassi et al. · Emergency Radiology · 2024 · 12 citations · Full text